Benzinga | Aug 9, 2021 05:25PM EDT

Catalyst Pharmaceuticals Q2 Adj. EPS $0.16 Beats $0.09 Estimate, Sales $36.40M Beat $31.51M Estimate

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.09 by 77.78 percent. This is a 77.78 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $36.40 million which beat the analyst consensus estimate of $31.51 million by 15.52 percent. This is a 22.95 percent increase over sales of $29.61 million the same period last year.